PI3Kδ/γ-IN-2 is a potent and orally active dual inhibitor targeting PI3Kδ (IC50=1 nM) and PI3Kγ (IC50=4.3 nM). It is a valuable research tool for studying B-cell malignancies and immune signaling pathways in both in vitro cellular assays and in vivo preclinical models.